{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:29:11Z","timestamp":1760142551641,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.biopha.2008.10.006","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T04:56:08Z","timestamp":1225515368000},"page":"571-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy"],"prefix":"10.1016","volume":"63","author":[{"given":"Dijana","family":"Jovanovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djurdjica","family":"Jovovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevena","family":"Mihailovic-Stanojevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran","family":"Miloradovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radomir","family":"Naumovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovan","family":"Dimitrijevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nebojsa","family":"Maksic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ljubica","family":"Djukanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2008.10.006_bib1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.CIR.61.6.1179","article-title":"Perspectives on systolic hypertension. The Framingham study","volume":"61","author":"Kannel","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2008.10.006_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/080370501753400601","article-title":"The older hypertensive","volume":"10","author":"Birkenhager","year":"2001","journal-title":"Blood Press"},{"key":"10.1016\/j.biopha.2008.10.006_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.CIR.100.4.354","article-title":"Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study","volume":"100","author":"Franklin","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2008.10.006_bib4","unstructured":"Stolarz K, Staessen JA. Prognostic significance of pulse pressure. 9th European meeting on cardionephrology, Italy. Editoriale Bios; 2002. p. 257\u201360."},{"key":"10.1016\/j.biopha.2008.10.006_bib5","first-page":"594","article-title":"Cardiovascular risks related to increased diastolic, systolic and pulse pressure. An epidemiologist's point of view","volume":"47","author":"Franklin","year":"1999","journal-title":"Pathol Biol"},{"key":"10.1016\/j.biopha.2008.10.006_bib6","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1001\/jama.287.20.2677","article-title":"Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT)","volume":"287","author":"Domanski","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.biopha.2008.10.006_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1523-1755.2002.00173.x","article-title":"Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis","volume":"61","author":"Tozawa","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.biopha.2008.10.006_bib8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.HYP.30.6.1410","article-title":"Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population","volume":"30","author":"Benetos","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2008.10.006_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/dmrr.598","article-title":"Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study","volume":"22","author":"Mannucci","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.biopha.2008.10.006_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/08860229809045134","article-title":"Effects of captopril on morphologic changes in kidney of spontaneously hypertensive rats with adriamycin nephropathy","volume":"20","author":"Jovanovic","year":"1998","journal-title":"Ren Fail"},{"key":"10.1016\/j.biopha.2008.10.006_bib11","first-page":"308","article-title":"The size of the juxtaglomerular apparatus in diabetic glomerulosclerosis and its correlation with arteriosclerosis and arterial hypertension: a morphometric light microscopic study on human renal biopsies","volume":"8","author":"Bader","year":"1977","journal-title":"Clin Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2008.10.006_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000186033","article-title":"Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function","volume":"55","author":"Mann","year":"1990","journal-title":"Nephron"},{"key":"10.1016\/j.biopha.2008.10.006_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biopha.2008.10.006_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1464-5491.2004.01122.x","article-title":"Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials","volume":"21","author":"Siebenhofer","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.biopha.2008.10.006_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1291\/hypres.25.447","article-title":"Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist: beyond the renoprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation","volume":"25","author":"Kanazawa","year":"2002","journal-title":"Hypertens Res"},{"issue":"3-4","key":"10.1016\/j.biopha.2008.10.006_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2298\/SARH0204073J","article-title":"Slowing down of chronic renal failure progression with captopril in spontaneously hypertensive rats with adriamycin nephropathy","volume":"130","author":"Jovanovic","year":"2002","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.biopha.2008.10.006_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5414\/CNP63446","article-title":"Influence of carvedilol on chronic renal failure progression in spontaneously hypertensive rats with adriamycin nephropathy","volume":"63","author":"Jovanovi\u0107","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.biopha.2008.10.006_bib18","first-page":"72","article-title":"Hypertension and progression of nephropathy in diabetic and non-diabetic chronic kidney disease patients","volume":"11","author":"Stojceva-Taneva","year":"2007","journal-title":"Hippokratia"},{"key":"10.1016\/j.biopha.2008.10.006_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/FJC.0b013e3181673bc5","article-title":"Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis","volume":"51","author":"Sabino","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.biopha.2008.10.006_bib20","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/HJH.0b013e3282ef547f","article-title":"Reduction of blood pressure variability by combination therapy in spontaneously hypertensive rats","volume":"25","author":"Xie","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.biopha.2008.10.006_bib21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/ki.1996.194","article-title":"Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease","volume":"49","author":"Foley","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.biopha.2008.10.006_bib22","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/ki.1996.484","article-title":"Predictors of stroke in patients receiving chronic hemodialysis","volume":"50","author":"Iseki","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.biopha.2008.10.006_bib23","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1161\/01.CIR.96.12.4254","article-title":"Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function","volume":"96","author":"Mitchell","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2008.10.006_bib24","first-page":"2396","article-title":"Risk evaluation and therapeutical implications of pulse pressure in primary arterial hypertension","volume":"127","author":"Bonner","year":"2002","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.biopha.2008.10.006_bib25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/hrt.2003.015552","article-title":"Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study","volume":"90","author":"Bellenger","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.biopha.2008.10.006_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cardfail.2006.10.011","article-title":"Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment","volume":"13","author":"Paraskevaidis","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.biopha.2008.10.006_bib27","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJM199812103392407","article-title":"Carvedilol","volume":"339","author":"Firshman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopha.2008.10.006_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1476-5381.1993.tb13610.x","article-title":"Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure","volume":"109","author":"Brooks","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopha.2008.10.006_bib29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bjp.0704329","article-title":"Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression","volume":"134","author":"Wong","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopha.2008.10.006_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000190295","article-title":"Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propranolol","volume":"77","author":"Van den Branden","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.biopha.2008.10.006_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0022-3565(24)37026-0","article-title":"Effects of the novel multiple action agent carvedilol on severe nephrosclerosis in renal ablated rats","volume":"283","author":"Rodriguez Perez","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopha.2008.10.006_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.amjhyper.2003.09.013","article-title":"Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing","volume":"17","author":"Kett","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.biopha.2008.10.006_bib33","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1073\/pnas.90.13.6189","article-title":"Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury","volume":"90","author":"Ohlstein","year":"1993","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332208003648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332208003648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:43:25Z","timestamp":1760093005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332208003648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0753332208003648"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2008.10.006","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2008.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}